NBSE - NeuBase +5.2% as Oppenheimer starts at Outperform November, 20 2019 05:58 PM NeuBase Therapeutics Inc. NeuBase Therapeutics (NASDAQ:NBSE) is building on a strong gain today, up 5.2% after hours as it gets an initiation at Outperform by Oppenheimer.More news on: NeuBase Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more ...